IP Library Granted Patent US 7,053,064
Granted Patent B2
US 7,053,064 · App. 10/703,695 · Granted May 30, 2006

Compounds for the treatment of tobacco dependence and withdrawal

Assignee: The McLean Hospital Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,053,064
App. No.
10/703,695
Granted
May 30, 2006
Kind
B2
Abstract

The invention provides methods for treating or suppressing tobacco or nicotine usage or dependence involving administration of a therapeutically-effective amount of a cytosine-containing or cytidine-containing compound, creatine-containing compound, adenosine-containing, or adenosine-elevating compound to a mammal.

Claims (6)

1. A method of treating or suppressing tobacco or nicotine dependence or usage, said method comprising administering to a human in need thereof a therapeutically-effective amount of a cytidine-containing compound further comprising choline.

2. The method of claim 1 , wherein said cytidine-containing compound is CDP-choline.

3. The method of claim 2 , wherein said CDP-choline is administered orally.

4. The method of claim 1 , wherein said administering is chronic.

5. The method of claim 1 , wherein said human is a child or adolescent.

6. The method of claim 1 , wherein said human is an older adult.

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 2, 2015
From: MCLEAN HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 037031/0732 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2004
From: LUKAS, SCOTT
To: MCLEAN HOSPITAL CORPORATION, THE
Reel/Frame 015294/0124 →
Continuity (2)
Provisional Application 6042497200 · Nov 8, 2002
Related Publication 20040167093A1 · Aug 26, 2004